EXAGEN INC. Adjustments to Additional Paid in Capital, Warrant Issued
EXAGEN INC. (XGN) reported Adjustments to Additional Paid in Capital, Warrant Issued of $12.78 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-20.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2023-03-20
- EXAGEN INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-06-30 was $12.78M.
- EXAGEN INC. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $12.78M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2021-12-31 | $12.78M 10-K · filed 2023-03-20 | |
| 2021-06-30 | $12.78M 10-Q/A · filed 2022-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |